HolsboerMaschmeyer NeuroChemie GmbH   Report issue

For profit Phase 4
Founded: Munich Germany (2010)
Status: Left NME R&D (2016)

Organization Overview

First Clinical Trial
2011
NCT02237937
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Depression (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 9